Does optimal HbA1c in diabetes differ according to drug treatment? An evaluation of national electronic database in Malta.
Drug treatment
HbA1c
Mortality
Type 2 diabetes
Journal
Diabetes & metabolic syndrome
ISSN: 1878-0334
Titre abrégé: Diabetes Metab Syndr
Pays: Netherlands
ID NLM: 101462250
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
received:
12
07
2021
revised:
21
02
2022
accepted:
25
03
2022
pubmed:
4
4
2022
medline:
4
5
2022
entrez:
3
4
2022
Statut:
ppublish
Résumé
A J-shaped relationship between HbA We selected patients on any type of treatment for diabetes from a national electronic database (n = 25,743) and linked to other databases, including laboratory database and the national mortality register. We observed a J-shaped or U-shaped association between HbA Our data confirm the J-shaped relationship between HbA
Sections du résumé
BACKGROUND AND AIMS
OBJECTIVE
A J-shaped relationship between HbA
METHODS
METHODS
We selected patients on any type of treatment for diabetes from a national electronic database (n = 25,743) and linked to other databases, including laboratory database and the national mortality register.
RESULTS
RESULTS
We observed a J-shaped or U-shaped association between HbA
CONCLUSIONS
CONCLUSIONS
Our data confirm the J-shaped relationship between HbA
Identifiants
pubmed: 35367912
pii: S1871-4021(22)00089-3
doi: 10.1016/j.dsx.2022.102475
pii:
doi:
Substances chimiques
Blood Glucose
0
Glycated Hemoglobin A
0
Hypoglycemic Agents
0
Sulfonylurea Compounds
0
Metformin
9100L32L2N
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
102475Informations de copyright
Copyright © 2022. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.